DUBLIN--(BUSINESS WIRE)--The "Radiopharmaceuticals - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East & Africa, and Latin America. Annual estimates and forecasts are provided for the period 2016 through 2024. Also, a five-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.
This report analyzes the worldwide markets for Radiopharmaceuticals in US$ Thousand by the following Segments:
- Diagnostic Radiopharmaceuticals
- Therapeutic Radiopharmaceuticals
The report profiles 61 companies including many key and niche players such as:
- Actinium Pharmaceuticals, Inc. (USA)
- Alliance Medical (UK)
- Alseres Pharmaceuticals, Inc. (USA)
- Avid Radiopharmaceuticals (USA)
- Bayer HealthCare Pharmaceuticals (Germany)
- Bracco Diagnostics, Inc. (USA)
- Cardinal Health, Inc. (USA)
- GE Healthcare (UK)
- Ion Beam Applications S.A (Belgium)
- Immunomedics, Inc. (USA)
- Jubilant Pharma (India)
- Lantheus Medical Imaging Inc. (USA)
- Medi-Radiopharma Ltd (Hungary)
- Nordion, Inc. (Canada)
- Peregrine Pharmaceuticals, Inc. (USA)
- PETNET Solutions Inc. (USA)
- Positron Corporation (USA)
- Triad Isotopes, Inc. (USA)
Key Topics Covered:
1. Industry Overview
2. Longstanding Growth Drivers
3. Product Overview
4. Product Innovations/Introductions
5. Recent Industry Activity
6. Focus On Select Players
7. Global Market Perspective
Total Companies Profiled: 61 (including Divisions
Subsidiaries 69)
- The United States (27)
- Canada (4)
- Japan (1)
-
Europe (28)
- France (4)
- Germany (5)
- The United Kingdom (4)
- Italy (2)
- Rest of Europe (13)
- Asia-Pacific (Excluding Japan) (8)
- Africa (1)
For more information about this report visit https://www.researchandmarkets.com/research/dv6kh6/global?w=4